Publications by authors named "Su-Qiao Yang"
Article Synopsis
- - This study analyzed 64 patients with Takayasu's arteritis and pulmonary artery involvement to differentiate between active and inactive disease stages and find better markers for disease activity.
- - Results showed that active stage patients were younger and exhibited symptoms like fever and chest pain more frequently, alongside higher inflammatory markers and pulmonary artery wall thickening compared to inactive patients.
- - The study concluded that chest pain, increased platelet count, and pulmonary artery wall thickening could serve as new indicators of disease activity, with active patients showing better right heart function and lower pulmonary vascular resistance.
Background: Pulmonary endarterectomy (PEA) is the preferred treatment for CTEPH patients which can significantly improve symptoms and pulmonary hemodynamics. Therefore, this retrospective study evaluated the long-term outcomes after pulmonary endarterectomy (PEA) and analyze the predictors of long-term outcomes for chronic thromboembolic pulmonary hypertension (CTEPH).
Methods: From 2002-2020, 76 CTEPH patients successfully discharged after PEA in Beijing Chaoyang Hospital were followed-up by scheduled clinical visits or telephone interviews.
A definitive diagnosis of heparin-induced thrombocytopenia (HIT) is difficult to make, especially in patients undergoing cardiac surgery. In this retrospective cohort study, we assessed the platelet count trends and the response to fondaparinux in a population of patients of suspected HIT after pulmonary endarterectomy (PEA). Patients enrolled in this study were over the age of 18 years, and survived longer than 7 days after PEA between January 1, 2011 and December 31, 2015.
View Article and Find Full Text PDF[Prognostic factors for acute pulmonary thromboembolism].
Zhonghua Jie He He Hu Xi Za Zhi
December 2013
Background: Polymorphisms are associated with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary thromboembolism (PTE), but no polymorphism specific to CTEPH but not PTE has yet been reported. Fibrin resistance is associated with CTEPH, but the mechanism has not been elucidated.
Methods: Polymorphisms were analyzed in 101 CTEPH subjects, 102 PTE subjects and 108 healthy controls by Massarray or restriction fragment length polymorphism (RFLP).